FrancophonIA/ELRC3.0 huggingface dataset:
English: - Capsule shell: - Gelatin - Titanium dioxide (E171) - Yellow iron oxide (E172) - Red iron oxide (E172)
Danish: Kapselskal: - Gelatine - Titandioxid (E171) - Gul jernoxid (E172) - Rød jernoxid (E172)
English: Only for carton box: Rivastigmine HEXAL 4.5 mg
Danish: Kun for kartonæske: Rivastigmine HEXAL 4,5 mg
English: Very common Common Common Common Uncommon Rare
Danish: Meget almindelig Almindelig Almindelig Almindelig Ikke almindelig Sjælden
English: - Printing ink: - Shellac - Red iron oxide (E172)
Danish: Trykfarve: - Shellac - Rød jernoxid (E172)
English: • Seeing things that are not there (hallucinations)
Danish: Ser ting, der ikke er der i virkeligheden (hallucinationer) Hurtig eller langsom hjerterytme (puls)
English: - Capsule shell: - Gelatin - Titanium dioxide (E171) - Yellow iron oxide (E172)
Danish: Kapselskal: - Gelatin - Titaniumdioxid (E171) - Gul jernoxid (E172)
English: How to take Rivastigmine HEXAL
Danish: Sådan skal du tage Rivastigmine HEXAL
English: A mild eye/mucosal irritation potential of rivastigmine was identified in a rabbit study.
Danish: I et kaninstudie blev der observeret et potentiale for mild øjen-/slimhindeirritation af rivastigmin.
English: Uncommon (may affect up to 1 in 100 people)
Danish: Ikke almindelig (kan ramme op til 1 patient ud af 100) Depression
English: Each capsule contains rivastigmine hydrogen tartrate corresponding to 4,5 mg rivastigmine.
Danish: Hver kapsel indeholder rivastigminhydrogentartrat svarende til 4,5 mg rivastigmin.
English: Each ml contains rivastigmine hydrogen tartrate corresponding to rivastigmine base 2.0 mg. - The other ingredients are: sodium benzoate, citric acid, sodium citrate, quinoline yellow WS dye (E104) and purified water.
Danish: - Øvrige indholdsstoffer er natriumbenzoat, citronsyre, natriumcitrat, vandopløselig quinolingult farve (E 104) og renset vand.
English: Each capsule contains 6 mg of rivastigmine (as hydrogen tartrate).
Danish: Hver kapsel indeholder 6 mg rivastigmin (som hydrogentartrat).
English: Each capsule contains rivastigmine hydrogen tartrate corresponding to 6 mg rivastigmine.
Danish: Hver kapsel indeholder rivastigminhydrogentartrat svarende til 6 mg rivastigmin.
English: Each ml contains 2.0 mg of rivastigmine (as hydrogen tartrate).
Danish: Hver ml indeholder 2 mg rivastigmin (som hydrogentartrat).
English: Rivastigmine HEXAL 1.5 mg hard capsules rivastigmine (as hydrogen tartrate)
Danish: Rivastigmine HEXAL 1,5 mg hårde kapsler rivastigmin (som hydrogentartrat)
English: Rivastigmine HEXAL 6 mg hard capsules rivastigmine (as hydrogen tartrate)
Danish: Rivastigmine HEXAL 6 mg hårde kapsler rivastigmin (som hydrogentartrat)
English: - Rivastigmine HEXAL 3 mg hard capsules, which contain an off-white to slightly yellow powder, have an orange cap and orange body, with a red imprint “RIV 3 mg” on the body.
Danish: - Rivastigmine HEXAL 3 mg hårde kapsler, som indeholder et råhvidt til svagt gulligt pulver, har en orange hætte og en orange skal med "RIV 3 mg" præget med rødt på kapselskallen.
English: Each capsule contains 1.5 mg of rivastigmine (as hydrogen tartrate).
Danish: Hver kapsel indeholder 1,5 mg rivastigmin (som hydrogentartrat).
English: Sandoz dd
Danish: Sandoz Pharmaceuticals DD
English: - if you have, or have ever had impaired kidney function.
Danish: - hvis du har eller har haft nedsat nyrefunktion.
English: Each capsule contains 4.5 mg of rivastigmine (as hydrogen tartrate).
Danish: Hver kapsel indeholder 4,5 mg rivastigmin (som hydrogentartrat).
English: - Rivastigmine HEXAL 1.5 mg hard capsules, which contain an off-white to slightly yellow powder, have a yellow cap and yellow body, with a red imprint “RIV 1.5 mg” on the body.
Danish: - Rivastigmine HEXAL 1,5 mg hårde kapsler, som indeholder et råhvidt til svagt gulligt pulver, har en gul hætte og en gul skal med "RIV 1,5 mg" præget med rødt på kapselskallen.
English: Common Common Common Common Uncommon Uncommon Very rare Not known
Danish: Almindelig Almindelig Almindelig Almindelig Ikke almindelig Ikke almindelig Meget sjælden Ikke kendt
English: - Rivastigmine HEXAL 4.5 mg hard capsules, which contain an off-white to slightly yellow powder, have a red cap and red body, with a white imprint “RIV 4.5 mg” on the body.
Danish: - Rivastigmine HEXAL 4,5 mg hårde kapsler, som indeholder et råhvidt til svagt gulligt pulver, har en rød hætte og en rød skal med "RIV 4,5 mg" præget med hvidt på kapselskallen.
English: Each capsule contains rivastigmine hydrogen tartrate corresponding to 1,5mg rivastigmine.
Danish: Hver kapsel indeholder rivastigminhydrogentartrat svarende til 1,5 mg rivastigmin.
English: Rivastigmine HEXAL 4.5 mg hard capsules rivastigmine (as hydrogen tartrate)
Danish: Rivastigmine HEXAL 4,5 mg hårde kapsler rivastigmin (som hydrogentartrat)
English: Each capsule contains rivastigmine hydrogen tartrate corresponding to 3 mg rivastigmine.
Danish: Hver kapsel indeholder rivastigminhydrogentartrat svarende til 3 mg rivastigmin.
English: Rivastigmine HEXAL 3 mg hard capsules rivastigmine (as hydrogen tartrate)
Danish: Rivastigmine HEXAL 3 mg hårde kapsler rivastigmin (som hydrogentartrat)
English: Each capsule contains 3 mg of rivastigmine (as hydrogen tartrate).
Danish: Hver kapsel indeholder 3 mg rivastigmin (som hydrogentartrat).
English: Fatigue and asthenia Malaise
Danish: Træthed og asteni Generel utilpashed Fald
English: Off-white to slightly yellow powder in a capsule with red cap and red body, with white imprint “RIV 4.5 mg” on the body.
Danish: Råhvidt til svagt gulligt pulver i en kapsel med rød hætte og rød skal, med ”RIV 4,5 mg” præget med hvidt på kapselskallen.
English: Off-white to slightly yellow powder in a capsule with orange cap and orange body, with red imprint “RIV 3 mg” on the body.
Danish: Råhvidt til svagt gulligt pulver i en kapsel med orange hætte og orange skal, med ”RIV 3 mg” præget med rødt på kapselskallen.
English: Common Common Common Uncommon Uncommon Very rare Not known
Danish: Almindelig Almindelig Ikke almindelig Ikke almindelig Meget sjælden Ikke kendt
English: - Rivastigmine HEXAL 6 mg hard capsules, which contain an off-white to slightly yellow powder, have a red cap and orange body, with a red imprint “RIV 6 mg” on the body.
Danish: - Rivastigmine HEXAL 6 mg hårde kapsler, som indeholder et råhvidt til svagt gulligt pulver, har en rød hætte og en orange skal med "RIV 6 mg" præget med rødt på kapselskallen.
English: Off-white to slightly yellow powder in a capsule with yellow cap and yellow body, with red imprint “RIV 1.5 mg” on the body.
Danish: Råhvidt til svagt gulligt pulver i en kapsel med gul hætte og gul skal, med "RIV 1,5 mg" præget med rødt på kapselskallen.
English: - if you have, or have ever had impaired liver function.
Danish: - hvis du har eller har haft nedsat leverfunktion.
English: Off-white to slightly yellow powder in a capsule with red cap and orange body, with red imprint “RIV 6 mg” on the body.
Danish: Råhvidt til svagt gulligt pulver i en kapsel med rød hætte og orange skal, med ”RIV 6 mg” præget med rødt på kapselskallen.
English: Check with your doctor or pharmacist if you are not sure.
Danish: - Tal med lægen eller apotekspersonalet, hvis du får bivirkninger.
English: (n=158) n/a
Danish: (n=158) ikke relevant
English: PSURs
Danish: Dosologi
English: Table 1 Infections and infestations
Danish: Infektioner og parasitære sygdomme
English: What Rivastigmine HEXAL looks like and contents of the pack
Danish: Rivastigmine HEXALs udseende og pakningstørrelse
English: Common Common Common Common Common Not known
Danish: Almindelig Almindelig Almindelig Almindelig Almindelig Ikke kendt
English: Each ml contains rivastigmine hydrogen tartrate corresponding to 2g rivastigmine.
Danish: Hver ml indeholder rivastigmin-hydrogentartrat svarende til 2 mg rivastigmin.
English: • Feeling tired or weak
Danish: Træthed- eller svaghedsfornemmelse Generel utilpashed
English: (n=165) n/a
Danish: (n=165) ikke relevant
English: If you take more Rivastigmine HEXAL than you should
Danish: Hvis du har taget for meget Rivastigmine HEXAL
English: Common (may affect up to 1 in 10 people)
Danish: Almindelig (kan ramme op til 1 patient ud af 10) Angst
English: Only for carton box: Rivastigmine HEXAL 3 mg
Danish: Kun for kartonæske Rivastigmine HEXAL 3 mg
English: • Heartburn
Danish: Halsbrand
English: Very rare (may affect up to 1 in 10,000 people)
Danish: Meget sjælden (kan ramme op til 1 patient ud af 10.000) Forhøjet blodtryk
English: Rare (may affect up to 1 in 1,000 people)
Danish: Sjælden (kan ramme 1 patient ud af 1.000) Brystsmerter
English: Uncommon Not known
Danish: Ikke almindelig Ikke kendt
English: • Aggression, feeling restless • Uneven heartbeat
Danish: Træthed- eller svaghedsfornemmelse Generel utilpashed Rysten eller følelse af forvirring Nedsat appetit
English: Common Common Uncommon
Danish: Almindelig Almindelig Ikke almindelig
English: • Chest pain
Danish: PSUR'er
English: (n=289) n/a
Danish: (n=289) ikke relevant
English: Posology
Danish: Svedtendens
English: (n=329) n/a
Danish: (n=329) ikke relevant
English: Common Uncommon Uncommon Not known
Danish: Almindelig Ikke almindelig Ikke almindelig Ikke kendt
English: Renal impairment
Danish: Søvnløshed Depression
English: HOW TO STORE RIVASTIGMINE HEXAL
Danish: Opbevaring af Rivastigmine HEXAL
English: Common Rare
Danish: Ikke almindelig
English: The European Commission granted a marketing authorisation valid throughout the European Union for Jalra on 19 November 2008.
Danish: Europa-Kommissionen udstedte en markedsføringstilladelse med gyldighed i hele Den Europæiske Union for Jalra den 19.november 2008.
English: The full EPAR for Jalra can be found on the Agency's website ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Danish: Den fuldstændige EPAR for Jalra findes på agenturets websted website ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
English: This is a summary of the European public assessment report (EPAR) for Jalra.
Danish: Dette dokument er et sammendrag af den europæiske offentlige vurderingsrapport (EPAR) for Jalra.
English: Other information about Jalra
Danish: Andre oplysninger om Jalra
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Jalra.
Danish: Det forklarer, hvordan Udvalget for Lægemidler til Mennesker (CHMP) vurderede lægemidlet og nåede frem til sin udtalelse til fordel for udstedelse af en markedsføringstilladelse og til sine anbefalinger om anvendelsesbetingelserne for Jalra.
English: Jalra is a medicine that contains the active substance vildagliptin.
Danish: Jalra er et lægemiddel, der indeholder det aktive stof vildagliptin.
English: For more information about treatment with Jalra, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Danish: Hvis du ønsker yderligere oplysninger om behandling med Jalra, kan du læse indlægssedlen (også en del af denne EPAR) eller kontakte din læge eller dit apotek.
English: The most common side effect with Jalra (seen in between 1 and 10 patients in 100) is dizziness.
Danish: Den hyppigste bivirkning ved Jalra (som ses hos mellem 1 og 10 patienter ud af 100) er svimmelhed.
English: Because vildagliptin has been associated with liver problems, patients should have tests to check their liver function before treatment with Jalra and at regular intervals during treatment.
Danish: Da vildagliptin er blevet sat i forbindelse med leverproblemer, skal patienterne undersøges for at kontrollere deres leverfunktion inden behandlingen med Jalra og med regelmæssige mellemrum under behandlingen.
English: In adults, the recommended dose of Jalra is:
Danish: Den anbefalede dosis af Jalra til voksne er:
English: Jalra should therefore be used only in patients for whom metformin is inappropriate either because of side effects occurring with metformin or because they have a condition that makes metformin unsuitable for them.
Danish: Jalra skal derfor kun anvendes hos patienter, hos hvem metformin er uhensigtsmæssigt enten på grund af de bivirkninger, der indtræffer, eller fordi de har en tilstand, som gør, at metformin ikke er hensigtsmæssigt for dem.
English: Jalra is not recommended for patients with liver problems.
Danish: Jalra anbefales heller ikke til patienter med leversygdom.
English: Jalra is used to treat type 2 diabetes mellitus.
Danish: Jalra anvendes til behandling af type 2 diabetes.
English: • one tablet in the morning (50 mg per day) when taken with a sulphonylurea.
Danish: • en tablet om morgenen (50 mg pr dag), når det tages sammen med et sulfonylurinstof.
English: What is the risk associated with Jalra?
Danish: Hvilken risiko er der forbundet med Jalra?
English: The CHMP also considered the use of Jalra on its own and concluded that it was effective in reducing blood glucose but was less effective than metformin.
Danish: CHMP analyserede også anvendelsen af Jalra alene og konkluderede, at det var effektivt til at reducere blodsukkeret, dog i mindre grad end metformin.
English: The CHMP noted that Jalra was effective as an add-on to metformin, a thiazolidinedione or a sulphonylurea (dual therapy), a sulphonylurea and metformin (triple therapy) or insulin with or without metformin, and concluded that the benefits of the add-on treatment outweigh the risks.
Danish: CHMP bemærkede, at Jalra var effektivt som tillægsbehandling til metformin, thiazolidinedion eller et sulfonylurinstof (dobbelt behandling), til et sulfonylurinstof og metformin (tredobbelt behandling) eller til insulin med eller uden metformin, og konkluderede, at fordelene ved tillægsbehandlingen opvejer risiciene.
English: Jalra has been studied in eleven main studies involving a total of over 5,000 patients with type 2 diabetes and insufficient control of blood glucose levels.
Danish: Jalra blev anvendt i elleve hovedundersøgelser, der tilsammen omfattede over 5 000 patienter med type 2-sukkersyge, hvis blodsukker ikke var tilfredsstillende reguleret.
English: Why has Jalra been approved?
Danish: Hvorfor blev Jalra godkendt?
English: For the full list of all side effects reported with Jalra, including side effects occurring when Jalra is taken with other antidiabetes medicines, see the package leaflet.
Danish: Den fuldstændige liste over alle de indberettede bivirkninger ved Jalra, hvis det anvendes sammen med andre lægemidler mod sukkersyge, fremgår af indlægssedlen
English: Jalra must not be used in people who are hypersensitive (allergic) to vildagliptin or any of the other ingredients.
Danish: Jalra bør ikke anvendes hos patienter, der er overfølsomme (allergiske) over for vildagliptin eller andre af indholdsstofferne.
English: Jalra is not recommended for patients who have moderate or severe problems with their kidneys, including those on haemodialysis (a blood clearance technique) with end-stage renal disease.
Danish: Jalra anbefales ikke til patienter med moderat eller svær nyresygdom, herunder patienter, der er i hæmodialyse (rensning af blodet med en kunstig nyre) og har nyresygdom i sent stadium.
English: Four studies compared the effects of Jalra, taken at doses of 50 or 100 mg a day for 24 weeks, with those of placebo, when used as an add-on to existing treatment with metformin (544 patients), pioglitazone (a thiazolidinedione, 463 patients), glimepiride (a sulphonylurea, 515 patients) or insulin (296 patients).
Danish: I fire undersøgelser blev virkningen af Jalra, 50 eller 100 mg dagligt i 24 uger, sammenlignet med placebo som tillægsbehandling til enten metformin (544 patienter), thiazolidindionet pioglitazon (463 patienter), sulfonylurinstoffet glimepirid (515 patienter) eller insulin (296 patienter).
English: • one tablet in the morning and another in the evening (100 mg per day), when used alone, with metformin, with a thiazolidinedione, with metformin plus a sulphonylurea, or with insulin (with or without metformin);
Danish: • en tablet om morgenen og en tablet om aftenen (100 mg pr. dag), når det tages alene, sammen med metformin, et thiazolidindion, metformin og et sulfonylurinstof eller insulin (med eller uden metformin)
English: What is Jalra?
Danish: Hvad er Jalra?
English: Its use in patients with heart disease should be limited to patients with mild disease.
Danish: Hos patienter med hjertesygdom bør det kun bruges, hvis sygdommen er af lettere grad.
English: Patients taking Jalra in addition to insulin, with or without metformin, had a reduction in HbA1c levels of 0.77 percentage points, compared with 0.05 percentage points in patients taking placebo in addition to insulin.
Danish: Patienter, der tog Jalra i tillæg til insulin, med eller uden metformin, oplevede et fald i HbA1c-niveauerne på 0,77 procent sammenlignet med 0,05 procent hos patienter, der tog placebo i tillæg til insulin.
English: In combination with glimepiride, both 50 mg and 100 mg daily doses caused a reduction of around 0.6 percentage points.
Danish: Sammen med glimepirid gav både 50 mg og 100 mg dagligt en reduktion på ca. 0,6 procent.
English: A further study compared Jalra with placebo as an add-on treatment in 318 patients who were already taking metformin and glimepiride.
Danish: Der blev også udført en yderligere undersøgelse, hvori Jalra blev sammenlignet med placebo som tillægsbehandling hos 318 patienter, som allerede tog metformin og glimepirid.
English: A further study compared Jalra with placebo as an add-on treatment in 449 patients who were already taking a stable dose of long-acting insulin.
Danish: Desuden blev Jalra i en anden undersøgelse sammenlignet med placebo som tillægsbehandling hos 449 patienter, som allerede tog en fast dosis længerevirkende insulin.
English: When used as an add-on to existing treatment for type 2 diabetes, Jalra was more effective than placebo in reducing HbA1c levels.
Danish: Som tillægsbehandling til anden medicin til behandling af type 2-sukkersyge var Jalra bedre end placebo til at sænke indholdet af HbA1c.
English: In the study comparing Jalra with metformin, significantly better results were seen with metformin: a reduction in HbA1c of 1.5 percentage points after 52 weeks compared with a reduction of around 1 percentage point in patients treated with Jalra.
Danish: blev der opnået væsentligt bedre resultater med metformin: et fald i indholdet af HbA1c på 1,5 procent efter 52 uger sammenlignet med et fald på ca. 1 procent hos patienter behandlet med Jalra.
English: In combination with metformin and glimepiride, 50 mg Jalra taken twice a day reduced HbA1c levels by 1 percentage point, compared with a reduction of 0.3 percentage points in patients taking placebo.
Danish: I en kombination med metformin og glimepirid reducerede 50 mg Jalra to gange dagligt HbA1cniveauet med 1 procent sammenlignet med en reduktion på 0,3 procent hos patienter, der tog placebo.
English: What is Jalra used for?
Danish: Hvad anvendes Jalra til?
English: With metformin and with pioglitazone, the 100 mg daily dose was more effective than the 50 mg daily dose, with a reduction in HbA1c levels of between 0.8 and 1.0 percentage points.
Danish: Sammen med metformin og med pioglitazon virkede en dosis på 100 mg dagligt bedre end 50 mg dagligt og gav en reduktion i indholdet af HbA1c på mellem 0,8 og 1,0 procent.
English: How has Jalra been studied?
Danish: Hvordan blev Jalra undersøgt?
English: How is Jalra used?
Danish: Hvordan anvendes Jalra?
English: What benefit has Jalra shown during the studies?
Danish: Hvilken fordel viser undersøgelserne, at der er ved Jalra?
English: Jalra used on its own was effective at reducing levels of HbA1c, but was less effective than the comparator medicines.
Danish: Jalra anvendt alene var effektivt til at reducere indholdet af HbA1c, dog mindre effektivt end de lægemidler, det blev sammenlignet med. I den undersøgelse, der sammelignede Jalra med metformin,
English: In the study involving 296 patients taking insulin, adding Jalra caused a greater reduction in HbA1c levels than adding placebo, but the size of this effect was small possibly due to the fact that the study included long-term patients who were less likely to show improvement..
Danish: I undersøgelsen af 296 patienter, der tog insulin, gav Jalra som tillægsbehandling et større fald i HbA1c-niveauet end placebo.
English: Type 2 diabetes is a disease in which the pancreas does not make enough insulin to control the level of glucose (sugar) in the blood or when the body is unable to use insulin effectively.
Danish: Ved type 2-sukkersyge producerer bugspytkirtlen enten ikke nok insulin til at regulere glukosen (sukkeret) i blodet, eller også er kroppen ikke i stand til at udnytte insulinet effektivt.Det aktive stof i Jalras, vildagliptin, er en dipeptidylpeptidase-IV (DPP-IV)- hæmmer.Det virker ved at blokere nedbrydningen af inkretinhormoner i kroppen.Disse hormoner udskilles efter et måltid og stimulerer bugspytkirtlen til at producere insulin.
English: How does Jalra work?
Danish: Hvordan virker Jalra?
English: By increasing levels of incretin hormones in the blood, vildagliptin stimulates the pancreas to produce more insulin when blood glucose levels are high.
Danish: Vildagliptin øger indholdet af incretiner i blodet.
English: Five of these studies looked at the effects of Jalra taken alone in a total of 3,644 patients, comparing it with placebo (a dummy treatment), metformin, rosiglitazone (a thiazolidinedione) or or gliclazide (a sulphonylurea).
Danish: Det blev her sammenlignet med placebo (virkningsløs behandling), metformin, rosiglitazon (et thiazolidindion) eller gliclazid (et sulfonylurinstof).
English: Vildagliptin also reduces the amount of glucose made by the liver, by increasing insulin levels and decreasing the levels of the hormone glucagon.
Danish: Det får bugspytkirtlen til at producere mere insulin, når blodsukkeret er højt.Vildagliptin virker ikke, når blodsukkeret er lavt.Vildagliptin nedsætter desuden leverens sukkerproduktion ved at øge insulinindholdet og sænke indholdet af hormonet glukagon.Sammenlagt sænker disse processer blodsukkeret og er derved med til at kontrollere type 2-diabetes.
English: Side effects are similar in children.
Danish: Der ses tilsvarende bivirkninger hos børn.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Kaletra on 20 March 2001.
Danish: Europa-Kommissionen udstedte en markedsføringstilladelse med gyldighed i hele Den Europæiske Union for Kaletra den 20. marts 2001.
English: The medicine is also well tolerated and its side effects are manageable.
Danish: Lægemidlet er også veltolereret, og dets bivirkninger kan håndteres.
English: The full EPAR for Kaletra can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Danish: Den fuldstændige EPAR for Kaletra findes på agenturets websted under: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
English: This is a summary of the European public assessment report (EPAR) for Kaletra.
Danish: Dette dokument er et sammendrag af den europæiske offentlige vurderingsrapport (EPAR) for Kaletra.
English: Other information about Kaletra
Danish: Andre oplysninger om Kaletra
English: The European Medicines Agency (EMA) therefore concluded that the benefits of Kaletra outweigh its risks and recommended that it be given marketing authorisation in the EU.
Danish: Det Europæiske Lægemiddelagentur (EMA) konkluderede derfor, at fordelene ved Kaletra opvejer risiciene, og anbefalede udstedelse af markedsføringstilladelse i EU.
English: HIV is the virus that causes acquired immune deficiency syndrome (AIDS).
Danish: Hiv er det virus, der forårsager erhvervet immundefektsyndrom (AIDS)
English: What measures are being taken to ensure the safe and effective use of Kaletra?
Danish: Hvilke foranstaltninger træffes der for at sikre risikofri og effektiv anvendelse af Kaletra?
English: Kaletra contains two active substances, lopinavir and ritonavir.
Danish: Kaletra indeholder to aktive stoffer, lopinavir og ritonavir.
English: It is not intended to provide practical advice on how to use Kaletra.
Danish: Det er ikke en praktisk vejledning i, hvordan Kaletra bør anvendes.